MedTrace Logo

Neonatal Antimicrobial Resistance and Outcome

NCT05743816 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2023-03-01

No results posted yet for this study

Summary

This is a multicentre observational study involving NNUs across the UK. Study personnel (Neonatologists and research Nurses) from these NNUs will identify eligible babies in whom a positive culture has been obtained.

This study will help identify the infections leading to death in babies on UK neonatal units, define the clinical characteristics of babies dying from infections, and describe the management of babies dying from infections with a specific focus in their antimicrobial treatment.

Conditions

  • Neonatal Infection

Sponsors & Collaborators

  • Antibiotic Research UK

    collaborator UNKNOWN

  • St George's, University of London

    lead OTHER

Principal Investigators

  • Eva Galiza, MD · St George's, University of London

Eligibility

Min Age
28 Days
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-30
Primary Completion
2023-09-30
Completion
2024-02-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05743816 on ClinicalTrials.gov